File(s) not publicly available
Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis
journal contributionposted on 2005-09-01, 00:00 authored by B Garner, C M Pariante, S J Wood, D Velakoulis, L Phillips, B Soulsby, W J Brewer, D J Smith, P Dazzan, G E Berger, Alison YungAlison Yung, M Van Den Buuse, R Murray, P D McGorry, C Pantelis
Background: We examined pituitary volume before the onset of psychosis in subjects who were at ultra-high risk (UHR) for developing psychosis. Methods: Pituitary volume was measured on 1.5-mm, coronal, 1.5-T magnetic resonance images in 94 UHR subjects recruited from admissions to the Personal Assessment and Crisis Evaluation Clinic in Melbourne, Australia and in 49 healthy control subjects. The UHR subjects were scanned at baseline and were followed clinically for a minimum of 1 year to detect transition to psychosis. Results: Within the UHR group, a larger baseline pituitary volume was a significant predictor of future transition to psychosis. The UHR subjects who later went on to develop psychosis (UHR-P, n = 31) had a significantly larger (+12%; p = .001) baseline pituitary volume compared with UHR subjects who did not go on to develop psychosis (UHR-NP, n = 63). The survival analysis conducted by Cox regression showed that the risk of developing psychosis during the follow-up increased by 20% for every 10% increase in baseline pituitary volume (p = .002). Baseline pituitary volume of the UHR-NP subjects was smaller not only compared with UHR-P (as described above) but also compared with control subjects (-6%; p = .032). Conclusions: The phase before the onset of psychosis is associated with a larger pituitary volume, suggesting activation of the HPA axis. © 2005 Society of Biological Psychiatry.
Pagination417 - 423
Publication classificationC1.1 Refereed article in a scholarly journal
CategoriesNo categories selected
Science & TechnologyLife Sciences & BiomedicineNeurosciencesPsychiatryNeurosciences & Neurologyhigh-riskhypothalamic-pituitary-adrenal axispituitarypsychosisschizophreniaDEXAMETHASONE SUPPRESSION TESTDRUG-NAIVE PATIENTSNEUROCOGNITIVE FUNCTIONSCHIZOPHRENIC-PATIENTS1ST-EPISODE PSYCHOSISMIFEPRISTONE RU-486HIPPOCAMPAL VOLUMEBIPOLAR DISORDERYOUNG-PEOPLEADRENAL AXIS